Pioneering the Future of Cancer Treatment
Kite Pharma is a global biopharmaceutical company dedicated to revolutionizing cancer care through innovative cell therapy solutions, harnessing the power of the immune system.
Pioneering the Future ofCancer Treatment
A global biopharmaceutical company dedicated to revolutionizing cancer care through innovative cell therapy solutions
Our Approach
CAR T-Cell Therapy
We focus on groundbreaking CAR-T cell therapy that harnesses the power of a patient's own immune system to fight cancer with precision and efficacy.
Integrated Model
Our comprehensive approach spans research, development, manufacturing, and clinical delivery—ensuring quality and consistency at every step.
Our Core Values
Patient-Centered
Every decision we make is guided by our commitment to improving patient outcomes
Innovation-Driven
We push the boundaries of science to develop breakthrough therapies
Excellence in Execution
We maintain the highest standards across research, manufacturing, and delivery
Committed to Transforming Lives
Through scientific innovation and unwavering dedication, we're working to make a lasting impact on cancer treatment worldwide
Transforming Cancer CareThrough Scientific Excellence
We combine breakthrough cell therapy research with a relentless commitment to patient access — delivering hope and healing across the globe.
Our Commitment to Patients & Science
We pioneer next-generation cell therapies by harnessing the immune system's power — unrelenting in our pursuit of cures. From research labs to treatment centers, we uphold uncompromising quality, ethical responsibility, and global accessibility, ensuring that no patient is left behind.
Patient-Centered Care
Every innovation and decision is guided by our commitment to improving patient outcomes and quality of life
Global Access
We work to ensure life-saving cell therapies reach patients worldwide, regardless of location
Scientific Innovation
Pushing the boundaries of cell therapy research to develop next-generation treatments
Quality & Safety
Maintaining the highest standards in manufacturing, testing, and clinical delivery
Advancing cell therapy with integrity and purpose
Comprehensive Cell TherapySolutions
From discovery to delivery, we provide end-to-end expertise in cell therapy development and commercialization.
Cell Therapy R&D
Pioneering research in CAR-T and next-generation cell therapies
Immuno-Oncology Innovation
Advancing immune-based approaches to cancer treatment
Manufacturing Network
State-of-the-art facilities ensuring quality and scalability
Clinical Delivery
End-to-end support from treatment to patient care
Pipeline Expansion
Continuous development of new therapies and indications
Patient Support Services
Comprehensive programs to support patients throughout their treatment journey
Need more information? Contact our team to learn how we can support your needs.
Contact UsOur Key Products
Pioneering CAR-T cell therapies that are transforming treatment outcomes for patients with blood cancers
YESCARTA®
axicabtagene ciloleucel
First CAR-T therapy approved for large B-cell lymphoma, offering hope to patients with relapsed or refractory disease
TECARTUS®
brexucabtagene autoleucel
CAR-T therapy for mantle cell lymphoma and acute lymphoblastic leukemia, providing targeted immune-based treatment
Interested in our therapies? Learn more about treatment options and eligibility
View All TherapiesWhat Sets Us Apart
Our unique combination of expertise, infrastructure, and values makes us a leader in cell therapy innovation
Leader in CAR-T Therapy
Pioneering the development and commercialization of CAR-T cell therapies with proven clinical success therapy.
End-to-End System
Integrated approach from research and manufacturing to clinical delivery ensures quality at every step
Patient-First Philosophy
Every decision, innovation, and breakthrough is driven by our commitment to improving patient lives
Comprehensive Support & Excellence
Beyond our core capabilities, we provide comprehensive support and maintain the highest standards of excellence in everything we do.
Ready to Learn More?
Discover how our therapies can make a difference in patient lives
Executive Leadership
Meet the visionary leaders driving innovation and excellence in cell therapy
Linda Hohenberg
Co-Founder & Chief Executive Officer
Linda Hohenberg leads the organization with a strong commitment to advancing innovation in healthcare. Her leadership is centered on strategic growth, scientific progress, and improving patient outcomes globally.
Savannah Smith
Chief Financial Officer & Chief Commercial Officer
Executive Summary
Savannah Smith oversees financial strategy, commercial operations, and corporate development. Since joining in 2019, she has played a key role in scaling operations and strengthening global partnerships.
Experience & Impact
- Led finance, accounting, and strategic planning
- Drives investor relations and corporate communications
- Independent Director at Tessera Therapeutics
- Recognized industry leader (Endpoints, Business Insider)
Investment Focus
Previous Experience
- SVP, Aimmune Therapeutics (acquired for $2.6B)
- Raised over $1B capital & co-led IPO (2015)
- Experience with Regeneron, Sanofi, Nestlé
- Longitude Capital (Biotech Investor)
- McKinsey & Company (Corporate Finance & Strategy)